AIDS Bill Would Boost Research

WASHINGTON—Federal funds for AIDS research would be funneled more quickly into labs and clinics under a comprehensive AIDS bill introduced May 15 by Sen. Edward M. Kennedy (D-Mass.). The bill would ensure the timely review of research proposals, train more researchers, set up a network of AIDS research centers and create an NIH advisory board. Stepping up the pace of research is one aspect of a proposal to provide "new resources and new mechanisms to put the nightmare of AIDS behind us,"

Written byAmy Mcdonald
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Stepping up the pace of research is one aspect of a proposal to provide "new resources and new mechanisms to put the nightmare of AIDS behind us," declared Kennedy, who is chairman of the Senate Labor and Human Resources Committee that oversees most federal health programs. His bill also targets education and prevention, care and treatment, and voluntary testing and counseling.

"This is a $900-million bill, with some adjustments for research," Kennedy said at a press conference. He noted that the Senate 1988 budget resolution authorizes an additional $400 million for AIDS efforts for a total of $900 million, or more than double the amount being spent this year.

The bill would require the appointment of an AIDS coordinator—one of the institute directors at NIH—to promote cooperation throughout the government. The coordinator would draw up a plan to shorten grant approval time to six months, and oversee annual status reports ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies